Eric F. Johnson
Pfizer (United States)(US)
Publications by Year
Research Areas
PARP inhibition in cancer therapy, DNA Repair Mechanisms, Pharmacogenetics and Drug Metabolism, Synthesis and biological activity, Mechanical Behavior of Composites
Most-Cited Works
- → ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor(2008)1,942 cited
- → ABC transporters: the power to change(2009)1,424 cited
- → The P450 Superfamily: Update on New Sequences, Gene Mapping, and Recommended Nomenclature(1991)1,094 cited
- → The P450 Gene Superfamily: Recommended Nomenclature(1987)814 cited
- → ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor Models(2007)764 cited
- → The P450 Superfamily: Updated Listing of All Genes and Recommended Nomenclature for the Chromosomal Loci(1989)610 cited